Ubs Group Ag Allarity Therapeutics, Inc. Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.22 - $31640.0 $3,059 - $440 Million	-13,907 Reduced 99.72%	39 $0
Q3 2022 Nov 10, 2022	BUY	$1.04 - $34160.0 $12,377 - $407 Million	11,901 Added 581.96%	13,946 $15,000
Q2 2022 Aug 10, 2022	SELL	$1.11 - $2.99 $2,701 - $7,277	-2,434 Reduced 54.34%	2,045 $3,000
Q1 2022 May 16, 2022	BUY	$1.93 - $10.75 $8,434 - $46,977	4,370 Added 4009.17%	4,479 $9,000
Q4 2021 Feb 14, 2022	BUY	$9.1 - $12.62 $991 - $1,375	109 New	109 $1,000

Ticker ALLR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,260,200
Market Cap $35M
Description
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; D...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.